The presence of dental disease can be a risk factor for recurrent Helicobacter pylori infection after eradication therapy: A 3-year follow-up

Background and study aim: We investigated whether dental disease might be associated with a higher recurrence of Helicobacter pylori infection after successful eradication by triple therapy.

Patients and methods: Consecutive patients with successful H. pylori eradication, defined by negative results for both histology and ¹³C-urea breath test (UBT) performed 6 weeks after triple therapy, were enrolled in the study. Each patient was scheduled for serial UBT and dental assessments at the end of the first, second, and third years. Patients were categorized into a “dental disease” group or “no dental disease” group at the first-year follow-up. Patients in the dental disease group whose dental disease had been cured during the second- and third-year follow-up periods, were transferred to a “dental treatment” group.

Results: The first-year H. pylori recurrence rate was higher in the 159 patients with dental disease than in those 200 patients without dental disease (13.2 % vs. 3.5 %, P < 0.001; relative risk [95 %CI], 4.2 [1.7 - 10.1]). At both the second-year and the third-year follow-up, the annual H. pylori recurrence rates were higher in the dental disease group than in the no dental disease group or dental treatment group (second year, 18.4 % vs. 2.8 % or vs. 5.7 %, P < 0.001; third year, 20 % vs. 3.8 % or vs. 6.3 %, P < 0.001).

Conclusion: The presence of dental disease could predispose to recurrent H. pylori infection after successful eradication. Dental surveillance and care after H. pylori eradication is a rational step for preventing recurrence of H. pylori, especially in those with dental diseases.

References

• 1 Malfertheiner P, Megraud F, O’Morain C. et al . Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus report.  Aliment Pharmacol Ther. 2002;  16 167-180
• 2 Gisbert J P. The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review.  Am J Gastroenterol. 2005;  100 2083-2099
• 3 Hildebrand P, Bardhan P, Rossi L. et al . Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults.  Gastroenterology. 2001;  121 792-798
• 4 Bardhan K D, Graham D Y, Hunt R H, O’Morain C A. Effects of smoking on cure of Helicobacter pylori infection and duodenal ulcer recurrence in patients treated with clarithromycin and omeprazole.  Helicobacter. 1997;  2 27-31
• 5 Carpinteero P, Blance M, Pajares J M. Ranitidine versus colloid bismuth subcitrate in combination with amoxicillin and metronidazole for eradicating Helicobacter pylori in patients with duodenal ulcers.  Clin Infect Dis. 1997;  25 1032-1037
• 6 Gisbert J P, Luna M, Gomez B. et al . Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients.  Aliment Pharmacol Ther. 2006;  23 713-719
• 7 Gurbuz A K, Ozel A M, Yazgan Y. et al . Oral colonization of Helicobacter pylori: Risk factors and response to eradication therapy.  South Med J. 2003;  96 244-247
• 8 Anand P S, Nandakumar K, Shenoy K T. Are dental plaque, poor oral hygiene, and periodontal disease associated with Helicobacter pylori infection?.  J Periodontol. 2006;  77 692-698
• 9 Gebara E C, Pannuti C, Faria C M. et al . Prevalence of Helicobacter pylori detected by polymerase chain reaction in the oral cavity of periodontitis patients.  Oral Microbiol Immunol. 2004;  19 277-280
• 10 Kolho K L, Holtta P, Alaluusua S. et al . Dental caries is common in Finnish children infected with Helicobacter pylori.  Scand J Infect Dis. 2001;  33 815-817
• 11 Miyabayashi H, Furihata K, Shimizu T. et al . Influence of oral Helicobacter pylori on the success of eradication therapy against gastric Helicobacter pylori.  Helicobacter. 2000;  5 30-37
• 12 Gebara E CE, Faria C M, Pannuti C. et al . Persistence of Helicobacter pylori in the oral cavity after systemic eradication.  J Clin Periodontol. 2006;  33 329-333
• 13 Okuda K, Kimizuka R, Katakura A. et al . Ecological and immunopathological implications of oral bacteria in Helicobacter pylori-infected disease.  J Periodontol. 2003;  74 123-128
• 14 Sheu B S, Cheng H C, Kao A W. et al . Pretreatment with Lactobacillus- and Bifidobacterium-containing yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy.  Am J Clin Nutr. 2006;  83 864-869
• 15 Kao A W, Cheng H C, Sheu B S. et al . Post-treatment 13C-urea breath test is predictive of antimicrobial resistance to H. pylori after failed therapy.  J Gen Intern Med. 2005;  20 139-142
• 16 Sheu B S, Wu J J, Lo C Y. et al . Lactobacillus and Bifidobacteria containing yogurt can improve the drug compliance of triple therapy for Helicobacter pylori eradication.  Aliment Pharmacol Ther. 2002;  16 1669-1675
• 17 Coticchia J M, Sugawa C, Tran V R. et al . Presence and density of Helicobacter pylori biofilms in human gastric mucosa in patients with peptic ulcer disease.  J Gastrointest Surg. 2006;  10 883-889
• 18 Carron M A, Tran V R, Sugawa C, Coticchia J M. Identification of Helicobacter pylori biofilms in human gastric mucosa.  J Gastrointest Surg. 2006;  10 712-717